Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
xtWacgkdEGx5aKSB
Listen
